Skip to content
Independent analysis of NHS open data
PharmaInsight

Risankizumab

Gastro-Intestinal System Chronic bowel disorders BNF 0105030C0
Data updated September 2024 Download CSV
1items

Dispensed in September 2024

0items

Rolling 12 months

£3,326

Net ingredient cost · September 2024

Figure 1. Risankizumab: national items dispensed by month

0 0.5 1 Sep 2024 1 Sep 2024: 1

Source: NHSBSA Prescription Cost Analysis, to September 2024

Download CSV
Embed this chart

At a glance

  • Therapeutic class Chronic bowel disorders
  • Presentations 1 shown
  • Average cost / item £3,326.09
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, September 2024

The individual products dispensed under Risankizumab this month.

Presentations of Risankizumab, September 2024
Presentation BNF code Items Net ingredient cost
Skyrizi 360mg/2.4ml solution for injection cartridges 0105030C0BBAAAA 1 £3,326

Source: NHSBSA Prescription Cost Analysis · to September 2024 OGL v3.0

Where Risankizumab is dispensed

The regions and dispensing practices with the highest Risankizumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Risankizumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Risankizumab with

Other medicines in the same BNF section, by prescribing volume.